FDA approves Android for Gmate SMART mobile diabetes monitoring system

Gmate SMART is latest innovation in diabetes management technology for your smartphone

| From
Photo: Gmate SMART

NEW YORK, N.Y., Dec. 2, 2015 (SEND2PRESS NEWSWIRE) -- Philosys, the maker of Gmate® products, announced today that the U.S. Food and Drug Administration (FDA) has approved clearance for the Gmate SMART Blood Glucose Monitoring System and App for Android™. The Gmate SMART is a small, portable blood glucose meter that plugs into the headphone jack of a smartphone and provides fast and accurate blood glucose test results. Together, the Gmate SMART Meter and App turn your smartphone into a mobile blood glucose monitoring system.

The FDA approval of Gmate SMART for Android is another important milestone for Philosys. The Gmate SMART App is now available for both iOS and Android users. This is the next critical step for Gmate mHealth technology.

The Gmate SMART Meter is the size of a quarter and connects to the headphone jack of the smartphone. The Gmate SMART App integrates diabetes management directly to the iOS and Android device, providing better diabetes management including goal setting, graphing and the ability to email or text your blood glucose test results directly to a family member or your healthcare provider. The Gmate SMART App stores an unlimited number of test results electronically with the date and time. A user can also add custom comments, actions or notes to each test result. The Gmate SMART is a faster, smarter way to manage and improve diabetes care. The Gmate SMART App is a free download on the App Store™ and Google Play™.

According to Mike Tickle, Senior VP of Sales, "As cloud technology grows, Philosys is working to create an App-to-Cloud secure connection in the next generation of updates." This will allow for improved communication and notifications between patients and physicians. The Gmate SMART App can provide appropriate automated responses as determined by the medical team. Adds Tickle, "Not only is Gmate SMART changing diabetes care by improving health and lifestyle, but it's also affordable. Most retail pharmacies are selling both the meter and box of 50 count strips at a low cost."

About Philosys:
Philosys is a manufacturing company that specializes in medical, diagnostics and analytical instruments. The range of services we provide covers the entire product cycle from concept through to manufacture. Philosys' philosophy is to develop cost-effective design and manufacturing solutions that satisfy our customer's vision. For more information and where to buy, visit

* PHOTO for media:

Android is a trademark of Google Inc.

Twitter: @Gmate_SMART #Philosys #diabetesmanagement

News Source:
For more information regarding this press release, please visit:
Like, Share, Save this press release:
  TWEET   SHARE   G+   PIN IT   STUMBLE   LinkedIn   Instapaper   Buffer

Shortlink to this press release:
The content of the above press release was provided by the “news source” (Philosys Inc.) or authorized agency, who is solely responsible for its accuracy. Send2Press® is the originating wire service for this story and content is Copr. © 2015 Philosys Inc. with newswire version Copr. © 2015 Send2Press (a service of Neotrope). All trademarks acknowledged.

Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
STORY READS for this single page only, as of Oct 23 2016:
[ count retired 8.4.16 ]

back to top
REFERENCES: Gmate SMART, diabetes monitoring, , news, press release from Philosys Inc., Dec 2, 2015, Devices and Research, Technology, Health, New York, New York, FDA approves Android for Gmate SMART mobile diabetes monitoring system